Novo Nordisk A/S Earnings Date, Estimates & History

+4.10 (+4.40 %)
(As of 08/4/2021 11:28 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume97,933 shs
Average Volume905,389 shs
Market Capitalization$228.93 billion
P/E Ratio33.76
Dividend Yield1.43%

Novo Nordisk A/S (NYSE:NVO) Earnings Information

Novo Nordisk A/S last issued its earnings results on May 4th, 2021. The reported $5.45 earnings per share for the quarter, beating the consensus estimate of $0.81 by $4.64. The firm earned $5.48 billion during the quarter, compared to analyst estimates of $5.02 billion. Novo Nordisk A/S has generated $2.76 earnings per share over the last year ($2.88 diluted earnings per share) and currently has a price-to-earnings ratio of 33.8. Earnings for Novo Nordisk A/S are expected to grow by 8.74% in the coming year, from $3.09 to $3.36 per share. Novo Nordisk A/S has confirmed that its next quarterly earnings report will be published on Thursday, August 5th, 2021.

Novo Nordisk A/S Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Novo Nordisk A/S (NYSE:NVO) Earnings Estimates

2021 EPS Consensus Estimate: $3.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$0.78$0.78$0.78 
Q2 20211$0.77$0.77$0.77 
Q3 20211$0.78$0.78$0.78 
Q4 20211$0.75$0.75$0.75 

Novo Nordisk A/S (NYSE NVO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
5/4/20213/31/2021$0.81$5.45+$4.64$0.88$5.02 billion$5.48 billion  
2/2/202112/31/2020$0.60$4.01+$3.41$0.64$4.91 billion$5.15 billion  
11/4/20209/30/2020$0.68$0.69+$0.01$0.69$4.75 billion$4.86 billion  
8/6/2020Q2 2020$0.64$0.67+$0.03$0.67$4.49 billion$4.43 billion
5/6/20203/31/2020$0.68$0.75+$0.07$0.75$4.70 billion$5.00 billion  
2/5/2020Q4 2019$0.55$0.55$0.55$4.83 billion$4.80 billion
11/1/20199/30/2019$0.62$0.64+$0.02$0.64$4.55 billion$4.51 billion  
8/9/2019Q2 2019$0.61$0.61$0.61$4.41 billion$4.52 billion
5/3/2019Q1 2019$0.62$0.66+$0.04$0.66$4.35 billion$4.46 billion
2/1/201912/31/2018$0.57$0.54($0.03)$0.54$4.36 billion$4.55 billion  
11/1/2018Q3 2018$0.58$0.58$0.58$4.11 billion$4.31 billion
8/8/2018Q2 2018$0.64$0.68+$0.04$0.68$4.33 billion$4.39 billion
5/2/2018Q1 2018$0.69$0.73+$0.04$0.73$4.49 billion$4.44 billion
2/1/2018Q4 2017$0.57$0.53($0.04)$0.53$4.27 billion$4.43 billion
11/1/2017Q3 2017$0.58$0.62+$0.04$0.62$4.30 billion$4.20 billion
8/10/2017Q2 2017$0.56$0.59+$0.03$0.59$4.29 billion$4.23 billion
5/3/2017Q1 2017$0.53$0.58+$0.05$0.58$4.11 billion$4.08 billion
2/2/2017Q4 2016$0.52$0.50($0.02)$0.50$4.33 billion$4.29 billion
10/28/2016Q3 2016$0.56$0.58+$0.02$0.58$4.22 billion$4.13 billion
8/5/2016Q2 2016$0.58$0.60+$0.02$0.60$4.21 billion$4.17 billion
4/29/2016Q1$0.53$0.55+$0.02$0.55$4.07 billion$4.02 billion  
2/3/2016Q4 2015$0.48$0.47($0.01)$0.47$4.16 billion$4.24 billion
10/29/2015Q3$0.47$0.49+$0.02$0.49$4.03 billion$3.99 billion
8/6/2015Q2 2015$0.48+$0.48$0.48$3.97 billion$4.01 billion
4/30/2015Q1$0.39$0.45+$0.06$0.33$25.13 billion$25.20 billion
1/30/2015Q4$2.48$0.38($2.10)$0.38$24.67 billion$24.59 billion
10/30/2014Q3 2014$0.42+$0.42$0.42$3.80 billion
8/7/2014Q2$2.60$0.48($2.12)$0.48$21.86 billion$21.63 billion
5/1/2014Q1$0.44$0.45+$0.01$0.45$20.83 billion$20.30 billion
1/30/2014Q4 2013$0.42+$0.42$0.42$3.97 billion
10/31/2013Q3 2013$0.44+$0.44$0.44$21.04 billion$20.51 billion  
8/8/2013Q2 2013$0.45+$0.45$0.45$21.09 billion$21.38 billion
5/1/2013Q1 2013$0.39+$0.39$0.39$19.73 billion$19.98 billion
1/31/2013$9.77$10.53+$0.76$20.83 billion$20.96 billion  
10/31/2012Q312$9.43$10.33+$0.90$57.10 million
8/9/2012Q2 2012$0.32+$0.32$0.32
4/27/2012Q1 2012$0.30+$0.30$0.30
2/2/2012Q4 2011$0.26$0.30+$0.04$0.30
10/27/2011Q3 2011$0.27$0.28+$0.01$0.28
8/4/2011Q2 2011$0.29$0.28($0.01)$0.28
2/2/2011Q4 2010$0.27$0.25($0.02)$0.25
10/27/2010Q3 2010$0.23+$0.23$0.23
8/19/2010Q2 2010$0.19$0.21+$0.02$0.21
4/30/2010Q1 2009$0.16+$0.16$0.16
2/2/2010Q4 2009$0.16+$0.16$0.16
10/29/2009Q3 2009$0.18+$0.18$0.18
1/29/2009Q4 2008$0.13+$0.13$0.13
10/30/2008Q3 2008$0.17+$0.17$0.17
4/30/2008Q1 2008$0.14+$0.14$0.14
1/31/2008Q4 2007$0.06+$0.06$0.06
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles

Novo Nordisk A/S (NYSE:NVO) Earnings Frequently Asked Questions

When will Novo Nordisk A/S announce their next quarterly earnings?

Novo Nordisk A/S has confirmed that its next quarterly earnings data will be published on Thursday, August 5th, 2021. Learn more on NVO's earnings history

When did Novo Nordisk A/S announce their last quarterly earnings?

Novo Nordisk A/S (NYSE:NVO) last announced its quarterly earning data on Tuesday, May 4, 2021. Learn more on NVO's earnings history

Did Novo Nordisk A/S beat their earnings estimates last quarter?

In the previous quarter, Novo Nordisk A/S (NYSE:NVO) reported $5.45 earnings per share (EPS) to beat the analysts' consensus estimate of $0.81 by $4.64. Learn more on NVO's earnings details

How can I read Novo Nordisk A/S's conference call transcript?

The conference call transcript for Novo Nordisk A/S's latest earnings report can be read online. Read Transcript

How much revenue does Novo Nordisk A/S generate each year?

Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $19.45 billion.

How much profit does Novo Nordisk A/S generate each year?

Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $6.46 billion. NVO has generated $2.76 earnings per share over the last four quarters.

What is Novo Nordisk A/S's price-to-earnings ratio?

Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 32.67 and a forward price-to-earnings ratio of 30.45. The price/earnings-to-growth ratio is 3.38.

What is Novo Nordisk A/S's EPS forecast for next year?

Novo Nordisk A/S's earnings are expected to grow from $3.09 per share to $3.36 per share in the next year, which is a 8.74% increase.

This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.